SoftOx Solutions AS (SOFTX) - Net Assets
Based on the latest financial reports, SoftOx Solutions AS (SOFTX) has net assets worth Nkr22.95 Million NOK (≈ $2.42 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Nkr33.93 Million ≈ $3.57 Million USD) and total liabilities (Nkr10.98 Million ≈ $1.16 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. For live market cap and overall valuation, see SOFTX company net worth.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Nkr22.95 Million |
| % of Total Assets | 67.65% |
| Annual Growth Rate | 28.05% |
| 5-Year Change | -74.17% |
| 10-Year Change | N/A |
| Growth Volatility | 1234.22 |
SoftOx Solutions AS - Net Assets Trend (2016–2025)
This chart illustrates how SoftOx Solutions AS's net assets have evolved over time, based on quarterly financial data.
Annual Net Assets for SoftOx Solutions AS (2016–2025)
The table below shows the annual net assets of SoftOx Solutions AS from 2016 to 2025. See SoftOx Solutions AS (SOFTX) balance sheet quality index to measure how much of total assets are equity-financed.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Nkr22.95 Million ≈ $2.42 Million |
-75.88% |
| 2024-12-31 | Nkr95.18 Million ≈ $10.02 Million |
+3922.42% |
| 2023-12-31 | Nkr2.37 Million ≈ $249.01K |
-85.22% |
| 2022-12-31 | Nkr16.01 Million ≈ $1.68 Million |
-81.99% |
| 2021-12-31 | Nkr88.85 Million ≈ $9.35 Million |
+16.57% |
| 2020-12-31 | Nkr76.22 Million ≈ $8.02 Million |
-11.85% |
| 2019-12-31 | Nkr86.47 Million ≈ $9.10 Million |
+500.12% |
| 2018-12-31 | Nkr14.41 Million ≈ $1.52 Million |
-46.33% |
| 2017-12-31 | Nkr26.85 Million ≈ $2.83 Million |
+982.03% |
| 2016-12-31 | Nkr2.48 Million ≈ $261.08K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to SoftOx Solutions AS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 0.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | Nkr22.95 Million | 100.00% |
| Total Equity | Nkr22.95 Million | 100.00% |
SoftOx Solutions AS Competitors by Market Cap
The table below lists competitors of SoftOx Solutions AS ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Desoto Resources Ltd
AU:DES
|
$26.44 Million |
|
Ocean Vantage Holdings Bhd
KLSE:0220
|
$26.45 Million |
|
Park Street A/S
CO:PARKST-A
|
$26.46 Million |
|
Otto Holding AS
IS:OTTO
|
$26.46 Million |
|
Good Way Technology Co Ltd
TWO:3272
|
$26.42 Million |
|
Plus Therapeutics Inc
NASDAQ:PSTV
|
$26.42 Million |
|
Italian-Thai Development Public Company Limited
F:NYVF
|
$26.40 Million |
|
Reka Industrial Oyj
HE:REKA
|
$26.39 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SoftOx Solutions AS's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 95,184,540 to 22,954,000, a change of -72,230,540 (-75.9%).
- Net loss of 10,813,000 reduced equity.
- New share issuances of 19,089,000 increased equity.
- Other factors decreased equity by 80,506,540.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Nkr-10.81 Million | -47.11% |
| Share Issuances | Nkr19.09 Million | +83.16% |
| Other Changes | Nkr-80.51 Million | -350.73% |
| Total Change | Nkr- | -75.88% |
Book Value vs Market Value Analysis
This analysis compares SoftOx Solutions AS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 9.83x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.14x to 9.83x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | Nkr0.66 | Nkr0.09 | x |
| 2017-12-31 | Nkr7.07 | Nkr0.09 | x |
| 2018-12-31 | Nkr3.81 | Nkr0.09 | x |
| 2019-12-31 | Nkr11.16 | Nkr0.09 | x |
| 2020-12-31 | Nkr9.15 | Nkr0.09 | x |
| 2021-12-31 | Nkr8.59 | Nkr0.09 | x |
| 2022-12-31 | Nkr1.55 | Nkr0.09 | x |
| 2023-12-31 | Nkr0.06 | Nkr0.09 | x |
| 2024-12-31 | Nkr0.05 | Nkr0.09 | x |
| 2025-12-31 | Nkr0.01 | Nkr0.09 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SoftOx Solutions AS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -47.11%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.48x
- Recent ROE (-47.11%) is above the historical average (-274.41%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | -250.51% | -6153.87% | 0.01x | 3.57x | Nkr-6.46 Million |
| 2017 | -35.04% | -940827.00% | 0.00x | 1.16x | Nkr-12.09 Million |
| 2018 | -89.73% | -299.06% | 0.18x | 1.62x | Nkr-14.37 Million |
| 2019 | -18.89% | -398.54% | 0.04x | 1.21x | Nkr-24.98 Million |
| 2020 | -49.08% | -380.17% | 0.11x | 1.15x | Nkr-45.03 Million |
| 2021 | -97.12% | -1092.14% | 0.07x | 1.21x | Nkr-95.17 Million |
| 2022 | -444.47% | -1000.07% | 0.09x | 4.86x | Nkr-72.74 Million |
| 2023 | -1667.07% | -565.17% | 0.07x | 41.09x | Nkr-39.69 Million |
| 2024 | -45.12% | -542.64% | 0.07x | 1.27x | Nkr-52.46 Million |
| 2025 | -47.11% | 0.00% | 0.00x | 1.48x | Nkr-13.11 Million |
Industry Comparison
This section compares SoftOx Solutions AS's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $159,139,430
- Average return on equity (ROE) among peers: -97.05%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SoftOx Solutions AS (SOFTX) | Nkr22.95 Million | -250.51% | 0.48x | $26.42 Million |
| Arcticzymes Technologies ASA (AZT) | $21.91 Million | -111.00% | 0.47x | $111.78 Million |
| Bergenbio ASA (BGBIO) | $122.70 Million | -113.51% | 0.27x | $7.75 Million |
| Circio Holding ASA (CRNA) | $417.73 Million | -23.45% | 0.35x | $354.43 Million |
| Exact Therapeutics AS (EXTX) | $45.10 Million | -107.17% | 0.36x | $4.93 Million |
| Lytix Biopharma AS (LYTIX) | $51.32 Million | -171.28% | 0.24x | $64.41 Million |
| Nykode Therapeutics ASA (NYKD) | $178.85 Million | 83.74% | 0.29x | $171.47 Million |
| Oncoinvent ASA (ONCIN) | $384.43 Million | -80.47% | 0.17x | $42.88 Million |
| PCI Biotech Holding ASA (PCIB) | $69.71 Million | -36.24% | 0.12x | $274.95K |
| Thor Medical ASA (TRMED) | $140.52 Million | -314.06% | 1.11x | $253.09 Million |
About SoftOx Solutions AS
SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that anti-infective therapy for airway infections in Norway. The company develops SIS-03, a lead clinical program that is in phase 2a to treatment of chronic airway infections. It also developing pan antimicrobial pharmaceuticals targeting bacteria, viruses, yeast, spores, and fungi. SoftOx So… Read more